Form 8-K - Current report:
SEC Accession No. 0001104659-21-077405
Filing Date
2021-06-07
Accepted
2021-06-07 08:15:25
Documents
14
Period of Report
2021-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118923d1_8k.htm   iXBRL 8-K 38316
2 EXHIBIT 99.1 tm2118923d1_ex99-1.htm EX-99.1 17268
6 GRAPHIC tm2118923d1_ex99-1img001.jpg GRAPHIC 7364
  Complete submission text file 0001104659-21-077405.txt   249593

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA icpt-20210607.xsd EX-101.SCH 3208
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20210607_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20210607_pre.xml EX-101.PRE 22725
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2118923d1_8k_htm.xml XML 3695
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 21998319
SIC: 2834 Pharmaceutical Preparations